TradingKey

關於 Delcath Systems Inc 公司

Delcath Systems, Inc. 是一家專注於治療原發性和轉移性肝癌的介入腫瘤學公司。該公司的產品 HEPZATO KIT（注射用 Hepzato（美法侖）/肝臟輸送系統）和 CHEMOSAT 美法侖肝臟輸送系統（CHEMOSAT）經皮肝灌注 (PHP) 旨在向肝臟施用高劑量化療藥物，同時在 PHP 過程中控制全身暴露和相關副作用。HEPZATO KIT 是一種藥物/設備組合產品，旨在將高劑量化療藥物直接輸送到肝臟，同時限制全身暴露和相關副作用。在歐洲，肝臟輸送系統是一種獨立的醫療設備，具有與 HEPZATO KIT 相同的設備組件，但沒有鹽酸美法侖，並以 CHEMOSAT 的商品名獲准銷售。在美國，HEPZATO 受美國食品藥品管理局 (FDA) 的藥品監管。

公司簡介

公司代碼DCTH

公司名稱Delcath Systems Inc

上市日期Oct 19, 2000

CEOMr. Gerard J. Michel

員工數量96

證券類型Ordinary Share

年結日Oct 19

公司地址566 Queensbury Avenue

城市QUEENSBURY

上市交易所NASDAQ Capital Market Consolidated

國家United States of America

郵編12804

電話15187438892

網址https://delcath.com/

公司代碼DCTH

上市日期Oct 19, 2000

CEOMr. Gerard J. Michel

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Gerard J. Michel

Chief Executive Officer, Director

319.33K

--

Ms. Sandra Pennell

Chief Financial Officer

70.30K

+15.15%

Mr. Kevin Muir

General Manager - Interventional Oncology

21.61K

+16.30%

Mr. John Richard Sylvester

Independent Non-Executive Chairman of the Board

10.55K

--

Ms. Martha S. Rook, Ph.D.

Chief Operating Officer

--

Mr. David Hoffman

Chief Compliance Officer, General Counsel, Corporate Secretary

--

Dr. Bridget A. Martell, M.D.

Independent Director

--

Dr. Vojislav Vukovic, M.D., Ph.D.

Chief Medical Officer

--

Ms. Elizabeth Czerepak

Independent Director

--

Mr. Steven A.J. Salamon

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Gerard J. Michel

Chief Executive Officer, Director

319.33K

--

Ms. Sandra Pennell

Chief Financial Officer

70.30K

+15.15%

Mr. Kevin Muir

General Manager - Interventional Oncology

21.61K

+16.30%

Mr. John Richard Sylvester

Independent Non-Executive Chairman of the Board

10.55K

--

Ms. Martha S. Rook, Ph.D.

Chief Operating Officer

--

Mr. David Hoffman

Chief Compliance Officer, General Counsel, Corporate Secretary

--

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

業務USD

名稱

營收

佔比

HEPZATO KIT

18.02M

91.10%

CHEMOSAT

1.76M

8.90%

暫無數據

業務

地區

業務USD

名稱

營收

佔比

HEPZATO KIT

18.02M

91.10%

CHEMOSAT

1.76M

8.90%

股東統計

更新時間: 7月31日週四

持股股東

股東類型

持股股東

佔比

Rosalind Advisors, Inc.

9.80%

The Vanguard Group, Inc.

4.00%

Deerfield Management Company, L.P.

2.33%

Vivo Capital, LLC

2.15%

ExodusPoint Capital Management, LP

2.01%

Other

79.70%

持股股東

佔比

Rosalind Advisors, Inc.

9.80%

The Vanguard Group, Inc.

4.00%

Deerfield Management Company, L.P.

2.33%

Vivo Capital, LLC

2.15%

ExodusPoint Capital Management, LP

2.01%

Other

79.70%

股東類型

持股股東

佔比

Hedge Fund

22.58%

Investment Advisor

12.55%

Investment Advisor/Hedge Fund

3.65%

Individual Investor

2.73%

Venture Capital

2.66%

Research Firm

2.04%

Private Equity

1.33%

Pension Fund

0.40%

Other

52.05%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

177

16.69M

47.96%

-955.13K

2025Q1

171

16.12M

46.80%

-1.98M

2024Q4

141

14.61M

45.75%

-298.57K

2024Q3

113

11.18M

39.89%

-3.98M

2024Q2

94

11.26M

40.31%

-2.23M

2024Q1

81

9.17M

35.81%

-967.18K

2023Q4

82

7.09M

31.51%

-2.72M

2023Q3

76

8.38M

57.84%

+174.15K

2023Q2

68

6.41M

45.63%

+3.12M

2023Q1

64

2.03M

20.29%

-877.12K

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Rosalind Advisors, Inc.

3.41M

9.8%

+513.08K

+17.69%

May 05, 2025

The Vanguard Group, Inc.

1.39M

4%

+169.26K

+13.82%

Mar 31, 2025

Deerfield Management Company, L.P.

813.11K

2.33%

+813.11K

--

Mar 31, 2025

Vivo Capital, LLC

750.20K

2.15%

-958.38K

-56.09%

Mar 31, 2025

ExodusPoint Capital Management, LP

699.35K

2.01%

+647.65K

+1252.79%

Mar 31, 2025

Susquehanna International Group, LLP

557.40K

1.6%

+138.79K

+33.16%

Mar 31, 2025

Gilder Gagnon Howe & Co. LLC

538.50K

1.55%

-73.73K

-12.04%

Mar 31, 2025

Perceptive Advisors LLC

462.42K

1.33%

+412.42K

+824.84%

Mar 31, 2025

Millennium Management LLC

422.07K

1.21%

+107.39K

+34.13%

Mar 31, 2025

Invesco Capital Management LLC

399.39K

1.15%

+399.39K

--

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

Simplify Propel Opportunities ETF

2.14%

SPDR S&P Health Care Equipment ETF

0.75%

Invesco Dorsey Wright SmallCap Momentum ETF

0.66%

ALPS Medical Breakthroughs ETF

0.32%

iShares Micro-Cap ETF

0.09%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.05%

ProShares Hedge Replication ETF

0.02%

ProShares UltraPro Russell2000

0.02%

Invesco Russell 2000 Dynamic Multifactor ETF

0.02%

iShares Russell 2000 Growth ETF

0.02%

Simplify Propel Opportunities ETF

佔比2.14%

SPDR S&P Health Care Equipment ETF

佔比0.75%

Invesco Dorsey Wright SmallCap Momentum ETF

佔比0.66%

ALPS Medical Breakthroughs ETF

佔比0.32%

iShares Micro-Cap ETF

佔比0.09%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.05%

ProShares Hedge Replication ETF

佔比0.02%

ProShares UltraPro Russell2000

佔比0.02%

Invesco Russell 2000 Dynamic Multifactor ETF

佔比0.02%

iShares Russell 2000 Growth ETF

佔比0.02%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Delcath Systems Inc

11.270USD

Delcath Systems Inc

11.270

概覽

公司

財務